Which is better: paravertebral (PV) or interpleural (IP) bupivacaine for breast surgery?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13771057

Enrollment

Registered

2003-09-12

Start date

2001-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Breast Surgery Breast

Interventions

Randomisation to two groups, standardised general anaesthetic, IP or PV block, recovery, test for failure, observed for pain, nausea and vomiting (N&V), patient-controlled analgesia (PCA) morphine co

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All patients having major breast surgery.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
1. Visual Analogue Pain Scores at rest and on movement 2. Nausea scale and vomiting episodes 3. Morphine and other analgesic consumption 4. Time to morphine demand 5. Hospital stay	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026